1. |
Hunt RH, Xiao SD, Megraud F, et al. World gastroenterology organisation global guideline: Helicobacter pylori in developing countries. J Dig Dis, 2011, 12(5): 319-326.
|
2. |
Zhuge L, Wang Y, Wu S, et al. Furazolidone treatment for Helicobacter Pylori infection: a systematic review and meta-analysis. Helicobacter, 2018, 23(2): e12468.
|
3. |
Chen L, He J, Wang L, et al. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial. Clin Exp Med, 2018, 18(4): 569-576.
|
4. |
弋东敏, 周炳喜, 丁松泽, 等. 含呋喃唑酮四联方案初次根除幽门螺杆菌的疗效及效价比评估. 胃肠病学和肝病学杂志, 2017, 26(6): 673-677.
|
5. |
Mazza JJ, Kryda MD. Tetracycline-induced hemolytic anemia. J Am Acad Dermatol, 1980, 2(6): 506-508.
|
6. |
Simpson MB, Pryzbylik J, Innis B, et al. Hemolytic anemia after tetracycline therapy. N Engl J Med, 1985, 312(13): 840-842.
|
7. |
李燕梅. 神经元特异性烯醇化酶评估中毒性脑病脑损伤的价值. 中华实用诊断与治疗杂志, 2014, 28(9): 893-894.
|
8. |
Risso FM, Serpero LD, Zimmermann LJ, et al. Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr, 2013, 102(10): e467-e472.
|
9. |
邱建武, 刁诗光, 刘晓燕, 等. 新生儿胆红素脑病监测 NSE 的意义. 中国妇幼健康研究, 2016, 27(12): 1445-1446.
|
10. |
陈清, 钱霜霜, 林锋. NSE 联合 NPY 对新生儿高胆红素血症脑损伤早期诊断的临床意义. 重庆医学, 2019, 48(10): 1784-1786.
|